La evolucion /

por Crusafont Pairó, Miguel, Melendez, B., Aguirre, E.
Publicado 1966.

P04.18 PROGNOSIS IMPACT OF THE REGIONAL DISTRIBUTION OF MGMT GENE METHYLATION ACCORDING TO THE CPGISLAND METHYLATOR PHENOTYPE AND AGE IN HIGH-GRADE GLIOMAS

por Mur, P., de Lope, A. Rodriguez, Hernandez-Iglesias, T., Diaz, F., Ribalta, T., Fiaño, C., Garcia, J.F., Rey, J.A., Mollejo, M., Meléndez, B.
Publicado 2014

P01.126 Frequent Tp53 and ATRX/DAXX gene alterations in giant cell IDH-Wildtype Glioblastomas

por Cantero Montenegro, D, D’Haene, N, Rodríguez de Lope, Á, Sepulveda, J, de Neve, N, Fiaño, C, Gutiérrez-Guamán, M, Mollejo, M, Salmon, I, Hernandez-Laín, A, Melendez, B
Publicado en Neuro Oncol (2018)

Stimulation of the midkine/ALK axis renders glioma cells resistant to cannabinoid antitumoral action

por Lorente, M, Torres, S, Salazar, M, Carracedo, A, Hernández-Tiedra, S, Rodríguez-Fornés, F, García-Taboada, E, Meléndez, B, Mollejo, M, Campos-Martín, Y, Lakatosh, S A, Barcia, J, Guzmán, M, Velasco, G
Publicado 2011

SLC45A2: A Melanoma Antigen with High Tumor Selectivity and Reduced Potential for Autoimmune Toxicity

por Park, J, Talukder, AH, Lim, SA, Kim, K, Pan, K, Melendez, B, Bradley, SD, Jackson, KR, Khalili, JS, Wang, J, Creasy, C, Pan, BF, Woodman, SE, Bernatchez, C, Hawke, D, Hwu, P, Lee, KM, Roszik, J, Lizée, G, Yee, C
Publicado en Cancer Immunol Res (2017)